As an increasing number of sponsors turn to master protocols as a way to reach decision points more quickly, the FDA says it’s ready to give new clinical trial designs a shot if they promise to help speed safe and effective drugs to market.
Rise of the Machines: AI Creeps into Clinical Trials
Artificial intelligence not only promises to increase the speed and accuracy of clinical trial recruitment and analysis but also to drastically reduce drug development costs.
